Immediate Impact

8 by Nobel laureates 22 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

Naturally occurring T cell mutations enhance engineered T cell therapies
2024 StandoutNature
ImmunoPET: Concept, Design, and Applications
2020 Standout
2 intermediate papers

Works of Michael Vesely being referenced

Rituximab treatment provides no clinical benefit in patients with pretreated advanced multiple myeloma
2006
Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)
1999

Author Peers

Author Last Decade Papers Cites
Michael Vesely 531 106 319 302 31 1.1k
Huaizheng Peng 754 127 397 410 21 1.3k
Pascale De Paepe 551 100 381 233 36 975
Young-Hyeh Ko 475 85 413 278 23 942
JP Marolleau 356 116 447 224 29 915
José Cabeçadas 750 141 754 270 64 1.3k
Roberta Riboni 456 43 330 182 40 1.1k
K. Henry 349 208 298 279 41 1.3k
Alessandra Marrelli 394 101 184 342 23 1.1k
Elizabeth Hyjek 331 152 444 246 26 1.2k
Martin‐Leo Hansmann 804 182 520 345 26 1.3k

All Works

Loading papers...

Rankless by CCL
2026